Seattle researchers building ‘biobank’ of patients’ blood to unlock the mysteries of the new coronavirus

The Institute for Systems Biology (ISB) and Swedish Health are building a “biobank” to study COVID-19’s impact on the human body.

According to Dr. Jim Heath, president of the Institute for Systems Biology, “Our goal really is to take these extremely deep dives into how it’s affecting a couple hundred patients or more and really track their disease trajectories over time.”

READ THE STORY at The Seattle Times »